| CAS No. | 1816989-16-8 |
|---|---|
| MDL No. | N/A |
| MF | C31H35ClN8O2 |
| MW | 587.10 |
| InChI Key | SCJNYBYSTCRPAO-LXBQGUBHSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | To Be Confirmed | $243 | In Stock | |
| 5 mg | 99.27% | $1010 | In Stock | |
| 10 mg | 99.27% | $1867 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Mevociclib (SY-1365) is a selective CDK7 inhibitor that exhibits anti-proliferative and apoptotic effects in solid tumor cell lines, demonstrating anti-tumor activity in hematological and multiple aggressive solid tumors.
| CAS No. | 1816989-16-8 |
|---|---|
| Product Name | Mevociclib |
| Heavy Atom Count | 42 | Rotatable Bond Count | 9 |
| Atom Stereo Count | 2 | Bond Stereo Count | 1 |
| HBA | 7 | HBD | 4 |
| TPSA | 127.930 Ų | Charge | 0 |
| Exact Mass | 586.25715 | Complexity | 1600.29 |
| pKa | 5.875 | XLogP | 5.273 |
